电子邮件 | ste***@***.com | 获取Email |
---|
电子邮件 | ste***@***.com | 获取Email |
---|
Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also working on the development of a COVID-19 drug FYB207 About Biosimilars: Since their introduction in the 1980s, biopharmaceuticals have revolutionized the treatment of serious diseases such as cancer, diabetes, rheumatoid arthritis, multiple sclerosis and eye diseases. In the coming years, many of these biotech drugs will lose their patent protection – and by 2020, medications with revenues of approximately USD 100 billion will be off patent. Biosimilars are follow-on versions of biopharmaceuticals, for which exclusivity has expired. They are approved via stringent regulatory pathways in highly regulated markets (such as EU, US, Japan, Canada, Australia) based on proven similarity of the biosimilar with the originator biopharmaceutical reference product. Global sales of biosimilars are estimated to exceed $15 billion by 2020. By 2030, analysts estimate that this figure could rise to over $60 billion. Contact: Formycon AG Fraunhoferstr. 15 82152 Martinsried/Planegg Germany phone +49 (0) 89 - 86 46 67 100 fax + 49 (0) 89 - 86 46 67 110 info@formycon.com
公司 | Formycon AG |
---|---|
职位 | Senior Director IP & Litigation |
地点 | Germany |
http://www.linkedin.com/in/stefan-peter-8786278 | |
部门 | master_engineering_technical,master_legal |
头衔 | Senior Director IP & Litigation |
Formycon AG Senior Director IP & Litigation
2022-07-01 -
Manager IP Biologics
2014-03-01 - 2022-06-01
Manager IP Litigation
2011-12-01 - 2014-02-01
Cytos Biotechnology AG Patent Attorney
2004-10-01 - 2011-11-01
Patent Agent
2002-11-01 - 2004-09-01
Stefan Peter 在 Formycon AG 担任 Senior Director IP & Litigation
Stefan Peter 在 Formycon AG 的职位是 Senior Director IP & Litigation
Stefan Peter 的电子邮件地址是 ste***@***.com
Stefan Peter 的电话号码是 -
Stefan Peter 的公司电话号码是 +498****
Stefan Peter 在 research 工作。
Stefan Peter 的一些同事包括Nicole Bleasdale、Stefan Peter、Cem Surkultay、Anja HuberMarta Blamowska、。
Stefan Peter联系方式: 电子邮件地址:ste***@***.com 电话号码:-
Stefan Peter 的个人领英是:http://www.linkedin.com/in/stefan-peter-8786278
Stefan Peter 的办公地点:Fraunhoferstrabe 15, Martinsried, Bavaria, DE, 82152
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd